Functional disorders of F0F1-ATPase in submitochondrial particles obtained from platelets of patients with a diagnosis of probable Alzheimer's disease;Alteración funcional de la F0F1-ATPasa en partículas submitocondriales obtenidas de plaquetas de pacientes con diagnóstico de enfermedad de Alzheimer probable

Revista de Neurologia

Volumn 40, Issue 2, 2005, Pages 81-85

  Martinez Cano E ^a,b   Ortiz Genaro, G ^a   Pacheco Moises F ^b   Macías Islas, Miguel Ángel ^a,c   Sanchez Nieto S ^d   Rosales Corral, S A ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Alzheimer's disease; F0F1 ATPase; Mitochondria; Neurodegeneration; Platelets; Submitochondrial particles

Indexed keywords

PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ALZHEIMER DISEASE; ARTICLE; CELL PH; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENERGY YIELD; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HYDROLYSIS; MALE; MITOCHONDRION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; SUBMITOCHONDRIAL PARTICLE; THROMBOCYTE; BLOOD; CYTOLOGY; DISEASE COURSE; ENZYMOLOGY; METABOLISM; PATHOPHYSIOLOGY; PH;

ALZHEIMER DISEASE; BLOOD PLATELETS; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; PROTON-TRANSLOCATING ATPASES; SUBMITOCHONDRIAL PARTICLES;

EID: 24344439378     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4002.2004150     Document Type: Article

References (39)

1. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399: 23-31.
2. Wurtman RJ. Choline metabolism as a basis for selective vulnerability of cholinergic neurons. Trends Neurosci 1992; 15: 117-22.
3. Epelbaum J, Apert C, Dournaud P. Molecular basis of Alzheimer's disease. In Galteau MM, Siest G, Henny J. Biologie prospective. Comptes rendus du 8. Colloque de Pont-a-Mousson. Paris: John Libbey Eurotext; 1993. p. 601-6.
4. Hoyer S. Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol Chem Neuropathol 1992; 16: 207-24.
5. Cheng B, Mattson MP. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF. Exp Neurol 1992; 117: 114-23.
6. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia 1994; 5: 36-41.
7. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reductions in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997; 42: 85-94.
8. Brown GG, Levine SR, Gorell JM, Pettegrew JW, Gdowski JW, Bueri JA, et al. In vivo 3'P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology 1989; 39: 1423-7.
9. Fukuyama H, Ogawa M, Yamauchi H, Yamauchi S, Kimura J, Yonekura Y, et al. Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med 1994; 35: 1-6.
10. Sokoloff L. Relationship between functional activity and energy metabolism in the nervous system: whether, where and why. In Lassen NA, Ingvar DH, Raichle ME, Friberg L, eds. Brain Work and Mental Activity. Quantitative Studies with Radioactive Tracers. Alfred Benzon Symposium VIII. Copenhagen: Munksgaard; 1991. p. 52-67.
11. Boyer PD. The ATP synthase: a splendid molecular machine. Annu Rev Biochem 1997; 66: 717-49.
12. Baracca A, Barogi S, Carelli V, Lenaz G, Solaini G. Catalytic activities of mitochondrial ATP synthase in patients with mitochondrial DNA T8993G mutation in the ATPase 6 gene encoding subunit a. J Biol Chem 2000; 275: 4177-82.
13. Boseti F, Brizzi F, Barogi S, Mancuso M, Sisiliano G, Tendi EA, et al. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging 2002; 23: 371-6.
14. Chandrasekaran K, Hatanpaa K, Brady DR, Stoll J, Martin LJ, Rapoport SI. Evidence for physiological down-regulation of brain oxidative phosphorilation in Alzheimer's disease. Exp Neurol 1996; 142: 180-8.
15. Schagger H, Ohm TG. Human diseases with defects in oxidative phosphorilation 2. F1F0-ATP synthase defects in Alzheimer's disease revealed by native blue native polyacrilamide gel electrophoresis (PAGE). Eur J Biochem 1995; 227: 916-21.
16. Dreux C, Launay JM. Blood platelets: neuronal model in psychiatric disorders. Encephale 1985; 11: 57-64.
17. Gattaz WF, Levy R, Cairns NJ, Forstl H, Braus DF, Maras A. Relevance of metabolism of membrane phospholipids for Alzheimer dementia. Fortschr Neurol Psychiatr 1996; 64: 8-12.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RL. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
19. González-Romo P, Sánchez-Nieto S, Gavilanes-Ruiz M. A modified colorimetric method for the determination of orthophosphate in the presence of high ATP concentrations. Anal Biochem 1992; 200: 235-8.
20. 1-ATP synthase. Eur J Biochem 2000; 267: 993-1000.
21. Rottenberg H, Moreno-Sánchez R. The proton pumping activity of H+ -ATPases: an improved fluorescence assay. Biochim Biophys Acta 1993; 1183: 161-70.
22. Zubenko GS, Winwood E, Jacobs B, Teply I, Stiffler S, Hughes HB, et al. Prospective study of risk factors Alzheimer's disease: results at 7.5 years. Am J Psychiatry 1999; 156: 50-7.
23. 1, the regulatory subunit of mitochondrial F-ATPase. EMBO Journal 2001; 20: 6990-6.
24. Manfredi G, Gupta N, Vázquez-Memije ME, Sadlock JE, Spinazzola A, De Vivo DC, et al. Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene. J Biol Chem 1999; 274: 9386-91.
25. Glaser E, Norling B, Kopecky J, Ernster L. Comparison of the effects of oligomycin and dicyclohexylcarbodiimide on mitochondrial ATPase and related reaction. Eur J Biochem 1982; 121: 525-31.
26. Mutisya EM, Bowling AC, Beal MF. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J Neurochem 1994; 63: 2179-84.
27. Parker WD, Parks JK, Filley CM, Kleinschmidt-Demasters BK. Electron transport chain defects in Alzheimer's disease brain. Neurology 1994; 44: 1090-6.
28. Parker WD, Parks JK. Cytochrome c oxidase in Alzheimer's disease brain. Neurology 1995; 45: 482-6.
29. Kish SJ, Bergeran C, Rajput A, Dozie S, Mastrogiacomo F, Chang LJ, et al. Brain cytochrome oxidase in Alzheimer's disease. J Neurochem 1992; 59: 776-9.
30. Curti D, Rognaoni F, Gasparini L, Cattaneo A, Paolillo M, Racchi M, et al. Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients. Neurosci Lett 1997; 236: 13-6.
31. Sheu KFR, Kim YT, Blass JP, Weksler ME. An immunohistochemical study of pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann Neurol 1985; 17: 444-9.
32. Mastrogiacomo F, Bergeron C, Kish SJ. Brain α-ketoglutarate dehydrogenase activity in Alzheimer's disease. J Neurochem 1993; 6: 2007-14.
33. Gibson GE, Park LC, Sheu KF, Blass JP, Calingasan NY. The α-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem Int 2000; 36: 97-112.
34. Rapoport SI, Hatanpää K, Brady DR, Chandrasekaran K. Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer Disease. Neurodegeneration 1996; 5: 473-6.
35. Roder HM, Ingram VM. Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios. J Neurosci 1991; 11: 3325-43.
36. Roder HM, Eden PA, Ingram VM. Brain protein kinase PK40" converts tau into a PHF-like form as found in Alzheimer's disease. Biochem Biophys Res Commun 1993; 193: 639-47.
37. Dyrks T, Dyrks E, Hartmann T, Masters C, Beyreuther K. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem 1992; 267: 18210-7.
38. Dyrks T, Dyrks E, Masters CL, Beyreuther K. Amyloidogenicity of rodent and human βA4 sequences. FEBS Lett 1993; 324: 231-6.
39. Troncoso JC, Costello A, Watson AL, Johnson GV. In vitro polymerization of oxidized tau into filaments. Brain Res 1993; 613: 313-6.